Taysha Gene Therapies Inc (TSHA) — Cash Flow Quality Index

Latest as of December 2023: -0.34x

Taysha Gene Therapies Inc (TSHA) has a Cash Flow Quality Index of -0.34x as of December 2023. Operating cash flow of $-16.12 Million is below net income of $47.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore TSHA total asset value for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.34x

Operating CF / Net Income

Operating Cash Flow

$-16.12 Million

USD

Net Income

$47.74 Million

USD

Data as of

Dec 2023

Most recent filing

Annual Cash Flow Quality Index for Taysha Gene Therapies Inc (None–None)

Year-by-year earnings quality comparison for Taysha Gene Therapies Inc. For live market cap and the full company financial profile, see TSHA market cap overview.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.